Platelet Activation Markers in Pediatric Cardiac Surgery
NCT00450151 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2012-03-01
Summary
In this study the focus will be on correlating the levels of platelet activation markers (proteins that are released when blood cells are activated)to the duration of cardiopulmonary bypass, temperature during cardiopulmonary bypass and the weight of the patient.
Conditions
- Coronary Disease
Sponsors & Collaborators
-
Weill Medical College of Cornell University
lead OTHER
Principal Investigators
-
Aarti Sharma, MD · Weill Medical College-New York Presbyterian Hospital
Eligibility
- Max Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2009-02-28
- Completion
- 2009-02-28
Countries
- United States
Study Locations
More Related Trials
-
Conventional Ultrafiltration Versus Dilutional Ultrafiltration in Pediatric CPB Patients
NCT07221630 ·Status: NOT_YET_RECRUITING
-
Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass
NCT02979158 ·Status: COMPLETED ·Phase: NA
-
Cardiopulmonary Circuits in the Pediatric Population
NCT00208728 ·Status: COMPLETED ·Phase: NA
-
Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution
NCT03326323 ·Status: COMPLETED
-
Management of Bleeding Following Cardiopulmonary Bypass
NCT00672516 ·Status: COMPLETED
-
Evaluation of Platelet Aggregability in the Release of CABG in Patients With ACS With DAPT.
NCT02516267 ·Status: COMPLETED ·Phase: NA
-
Antithrombin Enhancement May Improve Anticoagulation Efficiency in Infants Undergoing Cardiopulmonary Bypass for Cardiac Surgery
NCT01530737 ·Status: COMPLETED ·Phase: PHASE3
-
Intraoperative Hemodynamics in CABG
NCT05125315 ·Status: UNKNOWN
-
Heparin Management During Cardiopulmonary Bypass in Children
NCT00146653 ·Status: COMPLETED
-
Ultrafiltration in Pediatric Cardiac Surgery: An Observational Cohort Study
NCT05154864 ·Status: COMPLETED
-
Peri-Operative Morbidity and Quality of Life After Coronary Artery Bypass Graft (CABG)
NCT00248885 ·Status: COMPLETED ·Phase: NA
-
Prolonged Cardiopulmonary Bypass Time as Predictive Factor for in Hospital Infection
NCT04548167 ·Status: COMPLETED
-
Platelets and Complement Activation in Coronary Artery Bypass Graft Surgery (CABG)
NCT05033236 ·Status: COMPLETED
-
Hypothermic Versus Normothermic Cardiac Bypass in Patients Undergoing CABG Surgery, Effect on Coagulation; Randomized Controlled Trial
NCT04148404 ·Status: COMPLETED ·Phase: NA
-
Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)
NCT01698567 ·Status: TERMINATED ·Phase: PHASE1
-
Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery
NCT03894423 ·Status: ACTIVE_NOT_RECRUITING
-
Effects of Microplegia on Transfusion Rates After Cardiac Surgery
NCT05076604 ·Status: COMPLETED ·Phase: PHASE4
-
Aortic-Radial Pressure Gradients Post CPB
NCT03142815 ·Status: COMPLETED
-
Post-bypass Prophylactic IVIG in Infants and Neonates
NCT02043379 ·Status: COMPLETED ·Phase: NA
-
Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients
NCT00672672 ·Status: WITHDRAWN ·Phase: NA
-
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
NCT05189262 ·Status: RECRUITING
-
Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery
NCT03302195 ·Status: RECRUITING ·Phase: NA
-
Optimizing Pulsatility During Cardiopulmonary Bypass
NCT05344573 ·Status: RECRUITING
-
Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass
NCT01072955 ·Status: UNKNOWN ·Phase: PHASE3
-
Retransfusion or Not of Cardiotomy Blood
NCT04574128 ·Status: UNKNOWN ·Phase: NA